Latest Breaking News On - Presents phase - Page 1 : comparemela.com

PureTech Founded Entity Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week

VE303 receives Fast Track designation for prevention of recurrent C. difficile infection ahead of global pivotal Phase 3 study Exploratory analyses from the VE303 Phase 2 CONSORTIUM study identify. | May 9, 2023

United kingdomUnited statesJeffreyl silberRajita menonHuman servicesBiomedical advanced researchPuretech healthAmerican gastroenterological associationAmerican society for gastrointestinal endoscopyDepartment of healthSociety for surgery of the alimentary tractDevelopment authorityUniversity of massachusetts medical schoolSinai school of medicineDrug administrationAdministration for strategic preparedness

David Dworaczyk, PhD, Shares New Data on Nasal Epinephrine for Anaphylaxis

Data presented at the American Society for Clinical Pharmacology and Therapeutics annual meeting show promise for Utuly, a novel intranasal epinephrine spray for treating anaphylaxis.

United statesDavid dworaczykGrossig david dworaczykAmerican academy of allergyAmerican society for clinical pharmacologyDrug administrationAmerican societyClinical pharmacologyBryn pharmaAmerican academyPresents phaseNovel intranasal

Execution of Sub-license Agreement from Ping An-Shionogi Hong Kong to Ildong for Ensitrelvir Fumaric Acid (S-217622), a Therapeutic Drug for COVID-19, for South Korea

Execution of Sub-license Agreement from Ping An-Shionogi Hong Kong to Ildong for Ensitrelvir Fumaric Acid (S-217622), a Therapeutic Drug for COVID-19, for South Korea
shionogi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shionogi.com Daily Mail and Mail on Sunday newspapers.

Soult ukpyolsiSouth koreaPing anHong kongKyonggi doSouth koreanYun paul woongsupIsao teshirogiTatsumori yoshidaShionogi hong kongHead officeShionogi co ltdShionogi hong kong limited head officeIldong pharmaceutical co ltdMinistry of healthHokkaido university